Octagon Capital Advisors’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.1M Buy
3,672,000
+350,000
+11% +$1.91M 4.41% 9
2025
Q1
$20.9M Buy
+3,322,000
New +$20.9M 4.04% 5